GAITHERSBURG, Md., July 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will release its second
quarter financial results immediately after market close on Thursday, August 3, 2017. The company will then conduct a conference
call at 5:00 pm (Eastern Time) on the same day to discuss the financial results for the second quarter and year to date periods of
2017, recent business developments, revenue guidance for the third quarter of 2017, and revenue and net income guidance for full
year 2017.
This conference call can be accessed live by telephone or via webcast:
Live Teleconference Information:
Dial in number: (855) 766-6521
Conference ID: 29703370
Live Webcast Information:
Visit edge.media-server.com/m/p/g8vcpsxx for the live webcast feed.
A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty
products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats.
Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the
company may be found at emergentbiosolutions.com. Follow us @emergentbiosolu.
Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 BurrowsR@ebsi.com Media Contact: Lynn Kieffer Vice President, Corporate Communications 240-631-3391 KiefferL@ebsi.com
